Joanna J Phillips

Joanna J Phillips

UNVERIFIED PROFILE

Are you Joanna J Phillips?   Register this Author

Register author
Joanna J Phillips

Joanna J Phillips

Publications by authors named "Joanna J Phillips"

Are you Joanna J Phillips?   Register this Author

100Publications

-Reads

An oncolytic measles virus-sensitive Group 3 medulloblastoma model in immune-competent mice.

Neuro Oncol 2018 Jun 14. Epub 2018 Jun 14.

Department of Neurological Surgery, Brain Tumor Research Center, Helen Diller Family Comprehensive Cancer Center, University of California San Francisco (UCSF), San Francisco, California.

View Article
June 2018

A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment.

Cancer Cell 2018 May 19;33(5):874-889.e7. Epub 2018 Apr 19.

Department of Pediatrics, University of California San Francisco, San Francisco, CA 94143, USA; Eli and Edythe Broad Institute for Stem Cell Research and Regeneration Medicine, University of California San Francisco, San Francisco, CA 94143, USA; Department of Neurological Surgery and Brain Tumor Research Center, University of California San Francisco, San Francisco, CA 94143, USA; Department of Pediatrics, University of Cambridge and Wellcome Trust-MRC Stem Cell Institute, Hills Road, Cambridge CB2 0AN, UK. Electronic address:

View Article
May 2018

Mutant IDH1 gliomas downregulate phosphocholine and phosphoethanolamine synthesis in a 2-hydroxyglutarate-dependent manner.

Cancer Metab 2018 3;6. Epub 2018 Apr 3.

1Department of Radiology and Biomedical Imaging, University of California San Francisco, 1700 4th Street, Box 2532. Byers Hall 3rd Floor, Suite, San Francisco, CA 94143 USA.

View Article
April 2018

Comprehensive Molecular Profiling Identifies FOXM1 as a Key Transcription Factor for Meningioma Proliferation.

Cell Rep 2018 Mar;22(13):3672-3683

Department of Radiation Oncology, University of California, San Francisco, San Francisco, CA, USA; Department of Neurological Surgery, University of California, San Francisco, San Francisco, CA, USA. Electronic address:

View Article
March 2018

Characterization of Metabolic, Diffusion, and Perfusion Properties in GBM: Contrast-Enhancing versus Non-Enhancing Tumor.

Transl Oncol 2017 Dec 22;10(6):895-903. Epub 2017 Sep 22.

Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA, USA; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, San Francisco, CA, USA.

View Article
December 2017

Diffuse midline gliomas with subclonal H3F3A K27M mutation and mosaic H3.3 K27M mutant protein expression.

Acta Neuropathol 2017 Dec 23;134(6):961-963. Epub 2017 Oct 23.

Division of Neuropathology, Department of Pathology, University of California, San Francisco, 513 Parnassus Ave, Health Sciences West 451, Box 0102, San Francisco, CA, 94143, USA.

View Article
December 2017

Heparan Sulfate Glycosaminoglycans in Glioblastoma Promote Tumor Invasion.

Mol Cancer Res 2017 11 4;15(11):1623-1633. Epub 2017 Aug 4.

Department of Neurological Surgery, Brain Tumor Center, University of California, San Francisco, San Francisco, California.

View Article
November 2017

Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment.

Cancer Cell 2017 07;32(1):42-56.e6

Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; The Jackson Laboratory for Genomic Medicine, Farmington, CT, USA. Electronic address:

View Article
July 2017

Comparative analyses identify molecular signature of MRI-classified SVZ-associated glioblastoma.

Cell Cycle 2017 Apr 22;16(8):765-775. Epub 2017 Feb 22.

d Department of Neurological Surgery , University of California , San Francisco , CA , USA.

View Article
April 2017

Quantitative multi-modal MR imaging as a non-invasive prognostic tool for patients with recurrent low-grade glioma.

J Neurooncol 2017 03 25;132(1):171-179. Epub 2017 Jan 25.

Department of Radiology, University of California San Francisco, San Francisco,, CA, 94143, USA.

View Article
March 2017

A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma.

Cancer Cell 2017 03;31(3):424-435

Department of Neurology, University of California, San Francisco, CA 94158, USA; Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94158, USA; Department of Pediatrics, University of California, San Francisco, CA 94158, USA; Department of Neurological Surgery, University of California, San Francisco, CA 94158, USA. Electronic address:

View Article
March 2017

Safety Study: Intraventricular Injection of a Modified Oncolytic Measles Virus into Measles-Immune, hCD46-Transgenic, IFNαRko Mice.

Hum Gene Ther Clin Dev 2016 12 7;27(4):145-151. Epub 2016 Sep 7.

1 Department of Neurological Surgery, Helen Diller Family Comprehensive Cancer Center, University of California , San Francisco, San Francisco, California.

View Article
December 2016

Expression and prognostic impact of immune modulatory molecule PD-L1 in meningioma.

J Neurooncol 2016 12 13;130(3):543-552. Epub 2016 Sep 13.

Department of Neurological Surgery, University of California, San Francisco, 505 Parnassus Ave, M-779, San Francisco, CA, 94143, USA.

View Article
December 2016

Tissue mechanics promote IDH1-dependent HIF1α-tenascin C feedback to regulate glioblastoma aggression.

Nat Cell Biol 2016 Dec 7;18(12):1336-1345. Epub 2016 Nov 7.

Center for Bioengineering and Tissue Regeneration, Department of Surgery, University of California San Francisco, San Francisco, California 94143, USA.

View Article
December 2016

Activating NRF1-BRAF and ATG7-RAF1 fusions in anaplastic pleomorphic xanthoastrocytoma without BRAF p.V600E mutation.

Acta Neuropathol 2016 11 13;132(5):757-760. Epub 2016 Sep 13.

Division of Medical Genetics, Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA.

View Article
November 2016

Protein Analysis of Glioblastoma Primary and Posttreatment Pairs Suggests a Mesenchymal Shift at Recurrence.

J Neuropathol Exp Neurol 2016 Oct 18;75(10):925-935. Epub 2016 Aug 18.

From the Division of Neuropathology, Department of Pathology (MDW, GFR, JJP) and Department of Neurological Surgery (JJP), University of California San Francisco, San Francisco, California; and Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-University, Heidelberg, Germany (DER).

View Article
October 2016

Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations.

Brain Pathol 2016 09 14;26(5):569-80. Epub 2015 Dec 14.

Division of Neuropathology, Department of Pathology, University of California, San Francisco, CA.

View Article
September 2016

The Development of Reduced Diffusion Following Bevacizumab Therapy Identifies Regions of Recurrent Disease in Patients with High-grade Glioma.

Acad Radiol 2016 09 18;23(9):1073-82. Epub 2016 Jul 18.

Department of Radiology and Biomedical Imaging, Neuroradiology Section, University of California, Box 0628 Bldg 350 Parnassus Ave, Room 307, San Francisco, CA 94143; Department of Neurological Surgery, University of California, San Francisco, California. Electronic address:

View Article
September 2016

Magnetic resonance analysis of malignant transformation in recurrent glioma.

Neuro Oncol 2016 08 23;18(8):1169-79. Epub 2016 Feb 23.

Joint Graduate Program in Bioengineering (L.E.J., S.J.N.), Department of Radiology & Biomedical Imaging (E.N., J.M.L., M.P.O., S.J.N.), Department of Pathology (J.J.P.), Department of Neurological Surgery (J.J.P., A.M.M., M.S.B., S.M.C.), Department of Biostatistics and Epidemiology (A.M.M.),  University of California, San Francisco, San Francisco, California.

View Article
August 2016

PKM2 uses control of HuR localization to regulate p27 and cell cycle progression in human glioblastoma cells.

Int J Cancer 2016 Jul 2;139(1):99-111. Epub 2016 Mar 2.

The Department of Neurological Surgery and the Brain Tumor Research Center, Helen Diller Family Comprehensive Cancer Center, University of California-San Francisco, San Francisco, CA, 94158.

View Article
July 2016

MR Studies of Glioblastoma Models Treated with Dual PI3K/mTOR Inhibitor and Temozolomide:Metabolic Changes Are Associated with Enhanced Survival.

Mol Cancer Ther 2016 05 16;15(5):1113-22. Epub 2016 Feb 16.

Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California. Brain Tumor Research Center, University of California San Francisco, San Francisco, California.

View Article
May 2016

New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs.

Authors:
Dominik Sturm Brent A Orr Umut H Toprak Volker Hovestadt David T W Jones David Capper Martin Sill Ivo Buchhalter Paul A Northcott Irina Leis Marina Ryzhova Christian Koelsche Elke Pfaff Sariah J Allen Gnanaprakash Balasubramanian Barbara C Worst Kristian W Pajtler Sebastian Brabetz Pascal D Johann Felix Sahm Jüri Reimand Alan Mackay Diana M Carvalho Marc Remke Joanna J Phillips Arie Perry Cynthia Cowdrey Rachid Drissi Maryam Fouladi Felice Giangaspero Maria Łastowska Wiesława Grajkowska Wolfram Scheurlen Torsten Pietsch Christian Hagel Johannes Gojo Daniela Lötsch Walter Berger Irene Slavc Christine Haberler Anne Jouvet Stefan Holm Silvia Hofer Marco Prinz Catherine Keohane Iris Fried Christian Mawrin David Scheie Bret C Mobley Matthew J Schniederjan Mariarita Santi Anna M Buccoliero Sonika Dahiya Christof M Kramm André O von Bueren Katja von Hoff Stefan Rutkowski Christel Herold-Mende Michael C Frühwald Till Milde Martin Hasselblatt Pieter Wesseling Jochen Rößler Ulrich Schüller Martin Ebinger Jens Schittenhelm Stephan Frank Rainer Grobholz Istvan Vajtai Volkmar Hans Reinhard Schneppenheim Karel Zitterbart V Peter Collins Eleonora Aronica Pascale Varlet Stephanie Puget Christelle Dufour Jacques Grill Dominique Figarella-Branger Marietta Wolter Martin U Schuhmann Tarek Shalaby Michael Grotzer Timothy van Meter Camelia-Maria Monoranu Jörg Felsberg Guido Reifenberger Matija Snuderl Lynn Ann Forrester Jan Koster Rogier Versteeg Richard Volckmann Peter van Sluis Stephan Wolf Tom Mikkelsen Amar Gajjar Kenneth Aldape Andrew S Moore Michael D Taylor Chris Jones Nada Jabado Matthias A Karajannis Roland Eils Matthias Schlesner Peter Lichter Andreas von Deimling Stefan M Pfister David W Ellison Andrey Korshunov Marcel Kool

Cell 2016 Feb;164(5):1060-1072

Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), 69120 Heidelberg, Germany.

View Article
February 2016

Proportional upregulation of CD97 isoforms in glioblastoma and glioblastoma-derived brain tumor initiating cells.

PLoS One 2015 25;10(2):e0111532. Epub 2015 Feb 25.

Department of Neurological Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America.

View Article
January 2016

Glioma cells with the IDH1 mutation modulate metabolic fractional flux through pyruvate carboxylase.

PLoS One 2014 22;9(9):e108289. Epub 2014 Sep 22.

Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California, United States of America.

View Article
December 2015

Metabolic reprogramming in mutant IDH1 glioma cells.

PLoS One 2015 23;10(2):e0118781. Epub 2015 Feb 23.

Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California, United States of America; Brain Tumor Research Center, University of California San Francisco, San Francisco, California, United States of America.

View Article
December 2015

Glycosylation alterations in lung and brain cancer.

Adv Cancer Res 2015 7;126:305-44. Epub 2015 Feb 7.

Department of Neurological Surgery, Brain Tumor Research Center, University of California, San Francisco, California, USA; Department of Pathology, University of California, San Francisco, California, USA. Electronic address:

View Article
December 2015

Targeting a Plk1-Controlled Polarity Checkpoint in Therapy-Resistant Glioblastoma-Propagating Cells.

Cancer Res 2015 Dec 16;75(24):5355-66. Epub 2015 Nov 16.

Department of Neurosurgery, Brain Tumor Research Center, University of California San Francisco, San Francisco, California. Helen Diller Comprehensive Cancer Research Center, University of California San Francisco, San Francisco, California. Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California San Francisco, University of California San Francisco, San Francisco, California.

View Article
December 2015

Toward precision medicine in glioblastoma: the promise and the challenges.

Neuro Oncol 2015 Aug 1;17(8):1051-63. Epub 2015 May 1.

University of California San Francisco, San Francisco, California (M.D.P, J.J.P., A.M.M., S.M.C.); Translational Genomics Research Institute, Phoenix, Arizona (S.A.B., N.L.T., W.D.T., J.A.K., M.E.B., D.W.C., J.D.C., J.M.T.); Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts (K.L.L., P.Y.W.); University of Texas Health Science Center, San Antonio, Texas (J.G.K.); Memorial Sloan-Kettering Cancer Center, New York, New York (I.K.M.); The University of Texas M.D. Anderson Cancer Center, Houston, Texas (J.F.d.G.); University of Utah Huntsman Cancer Institute, Salt Lake City, Utah (H.C.); University of California Los Angeles, Los Angeles, California (T.F.C.); Iowa Spine and Brain Institute, Waterloo, Iowa (T.C.R.).

View Article
August 2015

IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism.

Cancer Res 2015 Aug 4;75(15):2999-3009. Epub 2015 Jun 4.

Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California.

View Article
August 2015

Measuring sulfatase expression and invasion in glioblastoma.

Methods Mol Biol 2015 ;1229:507-16

Department of Neurological Surgery, Brain Tumor Research Center, University of California, San Francisco, San Francisco, CA, USA.

View Article
June 2015

CDKN2A loss is associated with shortened overall survival in lower-grade (World Health Organization Grades II-III) astrocytomas.

J Neuropathol Exp Neurol 2015 May;74(5):442-52

From the Departments of Neurology, Pediatrics, and Neurosurgery, Stanford University School of Medicine, Stanford (HV); Department of Anatomic Pathology, University of California San Francisco Medical School (GFR, MP, AP); Division of Neuroepidemiology (HMH, TR, JKW, MRW, KMW), Departments of Neurological Surgery (REM, AMM, JJP, AP) and Epidemiology and Biostatistics (AMM); and Institute for Human Genetics, University of California San Francisco (JKW, MRW, KMW), San Francisco, California.

View Article
May 2015

SULF2, a heparan sulfate endosulfatase, is present in the blood of healthy individuals and increases in cirrhosis.

Clin Chim Acta 2015 Feb 31;440:72-8. Epub 2014 Oct 31.

Department of Anatomy, University of California, San Francisco, CA 94143, United States. Electronic address:

View Article
February 2015

Epidermal growth factor-like module containing mucin-like hormone receptor 2 expression in gliomas.

J Neurooncol 2015 Jan 9;121(1):53-61. Epub 2014 Sep 9.

Department of Neurological Surgery, University of California, San Francisco, CA, USA,

View Article
January 2015

A sensitive and specific histopathologic prognostic marker for H3F3A K27M mutant pediatric glioblastomas.

Acta Neuropathol 2014 Nov 9;128(5):743-53. Epub 2014 Sep 9.

Cancer Biology and Genetics Program, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY, 10065, USA,

View Article
November 2014

Signals that regulate the oncogenic fate of neural stem cells and progenitors.

Exp Neurol 2014 Oct 31;260:56-68. Epub 2013 Jan 31.

Department of Neurological Surgery, Brain Tumor Research Center, University of California, San Francisco, USA; Department of Neurology, Sandler Neurosciences Center, University of California, San Francisco, USA. Electronic address:

View Article
October 2014

Matrix regulators in neural stem cell functions.

Biochim Biophys Acta 2014 Aug 18;1840(8):2520-5. Epub 2014 Jan 18.

Department of Neurological Surgery, UCSF, San Francisco, CA, USA; Brain Tumor Research Center, UCSF, San Francisco, CA, USA; Neuropathology, Department of Pathology, UCSF, San Francisco, CA, USA. Electronic address:

View Article
August 2014

Hyperpolarized [1-13C] glutamate: a metabolic imaging biomarker of IDH1 mutational status in glioma.

Cancer Res 2014 Aug 29;74(16):4247-57. Epub 2014 May 29.

Departments of Radiology and Biomedical Imaging, Brain Tumor Research Center, University of California San Francisco, San Francisco, California

View Article
August 2014

Characterization of metabolites in infiltrating gliomas using ex vivo ¹H high-resolution magic angle spinning spectroscopy.

NMR Biomed 2014 May 5;27(5):578-93. Epub 2014 Mar 5.

University of California, Berkeley and University of California, San Francisco Graduate Program in Bioengineering, University of California, Berkeley/San Francisco, CA, USA; Department of Radiology and Biomedical Imaging, University of California, San Francisco (UCSF), CA, USA.

View Article
May 2014

Non-invasive in vivo assessment of IDH1 mutational status in glioma.

Nat Commun 2013 ;4:2429

Department of Radiology and Biomedical Imaging, University of California San Francisco, 1700 4th Street, San Francisco, California 94158, USA.

View Article
April 2014

Current management of choroid plexus carcinomas.

Neurosurg Rev 2014 Apr 26;37(2):179-92; discussion 192. Epub 2013 Sep 26.

Department of Neurological Surgery, University of California San Francisco, 505 Parnassus Ave., San Francisco, CA, 94117, USA.

View Article
April 2014

Cytogenetic prognostication within medulloblastoma subgroups.

J Clin Oncol 2014 Mar 3;32(9):886-96. Epub 2014 Feb 3.

David J.H. Shih, Marc Remke, Vijay Ramaswamy, Betty Luu, Yuan Yao, Xin Wang, Adrian M. Dubuc, Livia Garzia, John Peacock, Stephen C. Mack, Xiaochong Wu, Adi Rolider, A. Sorana Morrissy, Florence M.G. Cavalli, Claudia C. Faria, Stephen W. Scherer, Uri Tabori, Cynthia E. Hawkins, David Malkin, Eric Bouffet, James T. Rutka, and Michael D. Taylor, Hospital for Sick Children; David J.H. Shih, Marc Remke, Vijay Ramaswamy, Yuan Yao, Xin Wang, Adrian M. Dubuc, John Peacock, Stephen C. Mack, and Michael D. Taylor, University of Toronto, Toronto; Boleslaw Lach, McMaster University, Hamilton, Ontario; Jennifer A. Chan, University of Calgary, Calgary, Alberta; Steffen Albrecht, Adam Fontebasso, and Nada Jabado, McGill University, Montreal, Quebec, Canada; Paul A. Northcott, Andrey Korshunov, Marcel Kool, David T.W. Jones, and Stefan M. Pfister, German Cancer Research Center; Stefan M. Pfister, University Hospital Heidelberg, Heidelberg; Ulrich Schüller, Ludwig-Maximilians-University, Munich; Stefan Rutkowski, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Karel Zitterbart, Masaryk University School of Medicine; Karel Zitterbart and Leos Kren, University Hospital Brno, Brno, Czech Republic; Toshihiro Kumabe and Teiji Tominaga, Tohoku University Graduate School of Medicine, Sendai, Japan; Young Shin Ra, University of Ulsan, Asan Medical Center; Ji-Yeoun Lee, Byung-Kyu Cho, Seung-Ki Kim, and Kyu-Chang Wang, Seoul National University Children's Hospital, Seoul; Shin Jung, Chonnam National University Research Institute of Medical Sciences, Chonnam National University Hwasun Hospital and Medical School, Chonnam, South Korea; Peter Hauser and Miklós Garami, Semmelweis University, Budapest; László Bognár and Almos Klekner, University of Debrecen, Medical and Health Science Centre, Debrecen, Hungary; Shenandoah Robinson, Boston Children's Hospital; Scott L. Pomeroy, Harvard Medical School, Boston, MA; Ali G. Saad, University of Arkansas for Medical Sciences, Little

View Article
March 2014

Pyruvate kinase M2 expression, but not pyruvate kinase activity, is up-regulated in a grade-specific manner in human glioma.

PLoS One 2013 25;8(2):e57610. Epub 2013 Feb 25.

Department of Neurological Surgery, University of California San Francisco, San Francisco, California, United States of America.

View Article
January 2014

BRAF-V600E mutation in pediatric and adult glioblastoma.

Neuro Oncol 2014 Jan 4;16(2):318-9. Epub 2013 Dec 4.

Corresponding author: David H. Gutmann, MD, PhD, Department of Neurology, Washington University, Box 8111, 660 S. Euclid Avenue, St. Louis, MO 63110.

View Article
January 2014

Frequent truncating mutations of STAG2 in bladder cancer.

Nat Genet 2013 Dec 13;45(12):1428-30. Epub 2013 Oct 13.

1] Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University School of Medicine, Washington, DC, USA. [2] Department of Pathology, University of California, San Francisco, San Francisco, California, USA.

View Article
December 2013

The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas.

Mod Pathol 2013 Nov 14;26(11):1425-32. Epub 2013 Jun 14.

1] Division of Neuropathology, Department of Pathology, University of California, San Francisco, San Francisco, CA, USA [2] Division of Surgical Pathology, Department of Pathology, University of California, San Francisco, San Francisco, CA, USA.

View Article
November 2013

Na⁺/K⁺-ATPase β2-subunit (AMOG) expression abrogates invasion of glioblastoma-derived brain tumor-initiating cells.

Neuro Oncol 2013 Nov 25;15(11):1518-31. Epub 2013 Jul 25.

Corresponding Author: Andrew T. Parsa, MD, PhD, Department of Neurological Surgery, University of California, San Francisco, 505 Parnassus Ave., San Francisco, CA 94117.

View Article
November 2013

Mass spectral profiling of glycosaminoglycans from histological tissue surfaces.

Anal Chem 2013 Nov 29;85(22):10984-91. Epub 2013 Oct 29.

Center for Biomedical Mass Spectrometry, Department of Biochemistry, Boston University School of Medicine , Boston, Massachusetts 02118, United States.

View Article
November 2013

Pilocytic astrocytomas of the optic nerve and their relation to pilocytic astrocytomas elsewhere in the central nervous system.

Mod Pathol 2013 Oct 24;26(10):1279-87. Epub 2013 May 24.

Neuropathology Unit, Department of Anatomic Pathology, UCSF School of Medicine, San Francisco, CA, USA.

View Article
October 2013

Tuberculoma of the central nervous system.

J Clin Neurosci 2013 Oct 12;20(10):1333-41. Epub 2013 Jun 12.

Department of Neurological Surgery, University of California, San Francisco, 505 Parnassus Ave., Room 779M, San Francisco, CA 94143-0112, USA.

View Article
October 2013

Comparison of DSC-MRI post-processing techniques in predicting microvascular histopathology in patients newly diagnosed with GBM.

J Magn Reson Imaging 2013 Aug 19;38(2):388-400. Epub 2012 Dec 19.

The UC Berkeley - UCSF Graduate Program in Bioengineering, University of California, San Francisco, San Francisco, CA 94158, USA.

View Article
August 2013

Proteoglycans and their roles in brain cancer.

FEBS J 2013 May 6;280(10):2399-417. Epub 2013 Feb 6.

Department of Neurological Surgery, UCSF, San Francisco, CA 94158, USA.

View Article
May 2013

Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas.

PLoS One 2012 22;7(8):e43339. Epub 2012 Aug 22.

Department of Neurological Surgery, University of California San Francisco, San Francisco, California, United States of America.

View Article
April 2013

Characterization of a diffuse intrinsic pontine glioma cell line: implications for future investigations and treatment.

J Neurooncol 2012 Dec 17;110(3):305-13. Epub 2012 Sep 17.

Department of Neurological Surgery, Brain Tumor Research Center, University of California San Francisco, San Francisco, CA 94143-0520, USA.

View Article
December 2012

Epigenetic biomarkers of T-cells in human glioma.

Epigenetics 2012 Dec 29;7(12):1391-402. Epub 2012 Oct 29.

Department of Neurological Surgery, University of California San Francisco, San Francisco, CA USA.

View Article
December 2012

VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex.

Cancer Cell 2012 Jul;22(1):21-35

Department of Neurological Surgery, University of California, Helen Diller Family Cancer Research Center, San Francisco, CA 94143, USA.

View Article
July 2012

Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC.

Cancer Cell 2012 May;21(5):601-13

University of California, Department of Neurology, Brain Tumor Research Center and Helen Diller Family Comprehensive Cancer Center, San Francisco, CA 94158, USA.

View Article
May 2012

Novel therapeutic targets in the brain tumor microenvironment.

Oncotarget 2012 May;3(5):568-75

Department of Neurological Surgery, University of California San Francisco, USA.

View Article
May 2012

Heparan sulfate sulfatase SULF2 regulates PDGFRα signaling and growth in human and mouse malignant glioma.

J Clin Invest 2012 Mar 1;122(3):911-22. Epub 2012 Feb 1.

Department of Neurological Surgery, UCSF, San Francisco, California 94158, USA.

View Article
March 2012

Clinical stratification of glioblastoma based on alterations in retinoblastoma tumor suppressor protein (RB1) and association with the proneural subtype.

J Neuropathol Exp Neurol 2012 Jan;71(1):83-9

Division of Neuropathology, Department of Pathology, University of California, San Francisco, San Francisco, California 94143, USA.

View Article
January 2012

Magnetic resonance of 2-hydroxyglutarate in IDH1-mutated low-grade gliomas.

Sci Transl Med 2012 Jan;4(116):116ra5

Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, CA 94158, USA.

View Article
January 2012

Detection of early response to temozolomide treatment in brain tumors using hyperpolarized 13C MR metabolic imaging.

J Magn Reson Imaging 2011 Jun;33(6):1284-90

Surbeck Laboratory of Advanced Imaging, Department of Radiology and Biomedical Imaging, University of California, San Francisco, California, USA.

View Article
June 2011

Choline metabolism, proliferation, and angiogenesis in nonenhancing grades 2 and 3 astrocytoma.

J Magn Reson Imaging 2011 Apr;33(4):808-16

Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA, USA.

View Article
April 2011

EMR-3: a potential mediator of invasive phenotypic variation in glioblastoma and novel therapeutic target.

Neuroreport 2010 Nov;21(16):1018-22

Department of Neurological Surgery, Division of Neuropathology, University of California at San Francisco, San Francisco, California 94143, USA.

View Article
November 2010